This is a preview of subscription content, log in via an institution to check access.
REFERENCE
National Institute for Health and Clinical Excellence (NICE).NICE guidance recommends lenalidomide for multiple myeloma. Media Release: 17 Jun 2009. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
The UK NICE has released its final guidance regarding the use of lenalidomide in the treatment of multiple myeloma. Pharmacoecon. Outcomes News 581, 11 (2009). https://doi.org/10.2165/00151234-200905810-00038
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905810-00038